TOLTERODINE TARTRATE Drug Patent Profile
✉ Email this page to a colleague
When do Tolterodine Tartrate patents expire, and when can generic versions of Tolterodine Tartrate launch?
Tolterodine Tartrate is a drug marketed by Ajanta Pharma Ltd, Aurobindo Pharma Usa, Hetero Labs Ltd Iii, Inventia Hlthcare, Teva Pharms Usa, Torrent, Unichem, Utopic Pharms, Apotex Corp, Elysium, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Norvium Bioscience, and Unique. and is included in sixteen NDAs.
The generic ingredient in TOLTERODINE TARTRATE is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tolterodine Tartrate
A generic version of TOLTERODINE TARTRATE was approved as tolterodine tartrate by IVAX SUB TEVA PHARMS on February 23rd, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOLTERODINE TARTRATE?
- What are the global sales for TOLTERODINE TARTRATE?
- What is Average Wholesale Price for TOLTERODINE TARTRATE?
Summary for TOLTERODINE TARTRATE
US Patents: | 0 |
Applicants: | 15 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 184 |
Clinical Trials: | 16 |
Patent Applications: | 3,516 |
Drug Prices: | Drug price information for TOLTERODINE TARTRATE |
Drug Sales Revenues: | Drug sales revenues for TOLTERODINE TARTRATE |
What excipients (inactive ingredients) are in TOLTERODINE TARTRATE? | TOLTERODINE TARTRATE excipients list |
DailyMed Link: | TOLTERODINE TARTRATE at DailyMed |
Recent Clinical Trials for TOLTERODINE TARTRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
RenJi Hospital | N/A |
Shanghai Institute of Acupuncture, Moxibustion and Meridian | N/A |
University of California, San Francisco | Phase 4 |
Pharmacology for TOLTERODINE TARTRATE
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for TOLTERODINE TARTRATE
Anatomical Therapeutic Chemical (ATC) Classes for TOLTERODINE TARTRATE
Paragraph IV (Patent) Challenges for TOLTERODINE TARTRATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DETROL LA | Extended-release Capsules | tolterodine tartrate | 2 mg and 4 mg | 021228 | 1 | 2007-07-30 |
US Patents and Regulatory Information for TOLTERODINE TARTRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unique | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 204721-002 | Jan 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 202641-002 | Nov 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Unichem | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 205399-001 | Aug 5, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |